Aquestive Therapeutics, Inc. Uncategorized Contracts & Agreements

Consent Fee Letter, dated October 7, 2021, among Aquestive Therapeutics, Inc. and the Noteholder parties thereto (Filed With SEC on October 8, 2021)

Letter Agreement between the Company and A. Ernest Toth, Jr. , effective on June 15, 2021 (Filed With SEC on August 3, 2021)

Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 11, 2020)

Collateral Agreement dated as of July 15, 2019 among Aquestive Therapeutics, Inc., as Issuer, the Other Grantors from time to time party thereto, U.S. Bank National Association,... (Filed With SEC on July 16, 2019)

Agreement to Terminate CLA by and between MonoSol Rx, LLC and KemPharm, Inc., dated as of March 20, 2012 (Filed With SEC on June 27, 2018)

Agreement by and between MonoSol Rx, LLC and Indivior UK Limited, dated September 24, 2017 (Filed With SEC on June 27, 2018)

Commercial Exploitation Agreement by and between MonoSol Rx, LLC and Reckitt Benckiser Pharmaceuticals Inc., dated August 15, 2008 (as amended on August 19, 2009, November 13,... (Filed With SEC on June 27, 2018)

Form of Indemnity Agreement by and between Registrant and its directors and officers (Filed With SEC on June 27, 2018)

SUPPLYAGREEMENT (Filed With SEC on May 14, 2007)

LICENSEAGREEMENT (Filed With SEC on May 14, 2007)

AGREEMENT by and between Medtech Products inc. and MonoSolRx LLC (Filed With SEC on May 14, 2007)